Publicaciones en colaboración con investigadoras/es de Ikerbasque, Fundación Vasca para la Ciencia (17)

2023

  1. Interplay between hippocampal TACR3 and systemic testosterone in regulating anxiety-associated synaptic plasticity

    Molecular Psychiatry

2021

  1. Aberrant Synaptic PTEN in Symptomatic Alzheimer’s Patients May Link Synaptic Depression to Network Failure

    Frontiers in Synaptic Neuroscience, Vol. 13

  2. Altered cerebellar response to somatosensory stimuli in the Cntnap2 mouse model of autism

    eNeuro, Vol. 8, Núm. 5

  3. FORTIS: a live-cell assay to monitor AMPA receptors using pH-sensitive fluorescence tags

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. Preformulation Studies of a Stable PTEN-PDZ Lipopeptide Able to Cross an In Vitro Blood-Brain-Barrier Model as a Potential Therapy for Alzheimer’s Disease

    Pharmaceutical Research, Vol. 37, Núm. 10

2019

  1. Evidence of conditioned behavior in amoebae

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Editorial on the Special Issue: Molecules and Cognition

    Neuroscience

  2. Peptides Acting as Cognitive Enhancers

    Neuroscience, Vol. 370, pp. 81-87

2017

  1. PTEN: Local and Global Modulation of Neuronal Function in Health and Disease

    Trends in Neurosciences, Vol. 40, Núm. 2, pp. 83-91

2016

  1. A diet enriched with plant sterols prevents the memory impairment induced by cholesterol loss in senescence-accelerated mice

    Neurobiology of Aging, Vol. 48, pp. 1-12

  2. PTEN recruitment controls synaptic and cognitive function in Alzheimer's models

    Nature Neuroscience, Vol. 19, Núm. 3, pp. 443-453

  3. Specific cytoarchitectureal changes in hippocampal subareas in daDREAM mice

    Molecular Brain, Vol. 9, Núm. 1

2015

  1. Alzheimer's Disease and Mechanism-Based Attempts to Enhance Cognition

    Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors (Elsevier Inc.), pp. 193-231

  2. Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors

    Elsevier Inc., pp. 1-376

  3. Molecular Mechanisms of Drug-Induced Cognitive Enhancement

    Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors (Elsevier Inc.), pp. 43-59

  4. What is Cognitive Enhancement?

    Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors (Elsevier Inc.), pp. 1-9

2014

  1. DREAM controls the on/off switch of specific activity-dependent transcription pathways

    Molecular and Cellular Biology, Vol. 34, Núm. 5, pp. 877-887